MedPal AI PLC issues equity to complete eMARx acquisition
MedPal AI plc says it has issued 1,075,872 shares as part of the final consideration for the eMARx acquisition.
MedPal AI plc (“MedPal” or the “Company”) has announced the issue of 1,075,872 shares as final consideration for eMARx, alongside its total voting rights update. RNS Number: 5023T Medpal AI PLC 04 September 2026 4 September 2026